The Anti-HIV Drug Nelfinavir Exhibits Synergistic Activity with Tyrosine Kinase Inhibitors and Circumvents TKI-Resistance Conferred By T315I-Mutated BCR-ABL


ERBİLGİN Y., Desterke C., Bennaceur Griscelli A., TURHAN A.

64th American Society of Hematology Meeting, New Orleans, United States Of America, 10 - 13 December 2022, pp.3871-3872, (Full Text)

  • Publication Type: Conference Paper / Full Text
  • Doi Number: 10.1182/blood-2022-156350
  • City: New Orleans
  • Country: United States Of America
  • Page Numbers: pp.3871-3872
  • Istanbul University Affiliated: Yes